You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Performance Status

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Malignant Tumor of Lung, Poor Performance Status Trial in Guangzhou (Almonertinib)

Recruiting
  • Malignant Tumor of Lung
  • Poor Performance Status
  • Guangzhou, Guangdong, China
    Zhou Chengzhi
Apr 12, 2023

Nonsmall Cell Lung Cancer, Performance Status Trial in Winston-Salem (Pembrolizumab, Carboplatin, Paclitaxel)

Recruiting
  • Nonsmall Cell Lung Cancer
  • Performance Status
  • Winston-Salem, North Carolina
    Wake Forest Baptist Comprehensive Cancer Center
Dec 19, 2022

Immunotherapy in Advanced Non-small Cell Lung Cancer Poor

Not yet recruiting
  • Non-small Cell Lung Cancer
  • Questionnaires
  • Interview
  • Houston, Texas
    M D Anderson Cancer Center
Dec 1, 2022

Digitally-Captured Step Counts for Evaluating Performance Status

Recruiting
  • Cancer
  • +2 more
  • Wearable activity monitor
  • Los Angeles, California
    Cedars-Sinai Medical Center
Mar 30, 2022

Monitor Lung Cancer Patients Activity And Assess Performance

Recruiting
  • Non-Small Cell Lung Cancer (NSCLC)
  • Actigraphy device (wearable) and mobile application
  • Alcorcon, Madrid, Spain
  • +10 more
Jan 13, 2023

NSCLC (NSCLC) Trial in New York (Pembrolizumab)

Not yet recruiting
  • Non-Small Cell Lung Cancer (NSCLC)
  • New York, New York
    Mount Sinai Hospital
Jan 23, 2023

Ultra-rapid BRCA1/2 Status Screening Test in Theranostic

Not yet recruiting
  • Breast Cancer
  • Questionnaires
  • Communication of the results of the BRCA1/2 ultra rapid test
  • (no location specified)
Oct 26, 2023

Heart Diseases Trial in Ankara

Active, not recruiting
  • Heart Diseases
    • Ankara, Turkey
      Hacettepe University
    Oct 20, 2022

    NSCLC Trial in Rochester (Pembrolizumab, Pemetrexed (Chemotherapy), Nab-paclitaxel (Chemotherapy))

    Recruiting
    • Non-small Cell Lung Cancer
    • Rochester, New York
    • +1 more
    Jan 4, 2022

    Exercise, Recovery Trial (A regular training volume, A lower exercise volume group, A longer rest group)

    Not yet recruiting
    • Exercise
    • Recovery
    • A regular training volume
    • +2 more
    • (no location specified)
    Jun 5, 2023

    NSCLC Stage IV, KRAS P.G12C Trial in Worldwide (Adagrasib)

    Not yet recruiting
    • NSCLC Stage IV
    • KRAS P.G12C
    • Brussels, Belgium
    • +26 more
    Jan 3, 2023

    Cardiometabolic Syndrome Trial in Madrid (Vegan diet, Mediterranean diet)

    Active, not recruiting
    • Cardiometabolic Syndrome
    • Vegan diet
    • Mediterranean diet
    • Madrid, Spain
      Francisco de Vitoria University
    Aug 18, 2023

    NSCLC NSCLC Trial in Pittsburgh, Dallas (durvalumab)

    Completed
    • Non-Small Cell Lung Cancer NSCLC
    • Pittsburgh, Pennsylvania
    • +1 more
    Aug 2, 2022

    Pancreatic Cancer Trial in Cleveland (CPI 613, Oxaliplatin, Irinotecan)

    Active, not recruiting
    • Pancreatic Cancer
    • CPI 613
    • +4 more
    • Cleveland, Ohio
      University Hospitals Cleveland Medical Center, Case Comprehensiv
    Sep 14, 2022

    Exercise Performance Trial in Novi Sad (PhytoDyNAmic, Inulin)

    Completed
    • Exercise Performance
    • PhytoDyNAmic
    • Inulin
    • Novi Sad, Vojvodina, Serbia
      Applied Bioenergetics Lab at Faculty of Sport and PE
    Mar 9, 2022

    Gastrointestinal Discomfort, Performance Status Trial in Almere (G3P-01)

    Completed
    • Gastrointestinal Discomfort
    • Performance Status
    • G3P-01
    • Almere, Flevoland, Netherlands
      EB FlevoResearch
    Jun 8, 2022

    Stroke Trial in New Taipei City, Taipei city (Bifidobacterium longum OLP-01, Placebo)

    Active, not recruiting
    • Stroke
    • Bifidobacterium longum OLP-01
    • Placebo
    • New Taipei City, Taiwan
    • +2 more
    Jul 25, 2022

    Metastatic Colorectal Adenocarcinoma Trial in United States (Regorafenib)

    Active, not recruiting
    • Metastatic Colorectal Adenocarcinoma
    • Basking Ridge, New Jersey
    • +6 more
    Oct 28, 2021

    Temporomandibular Disorder, Bruxism Trial in Istanbul

    Recruiting
    • Temporomandibular Disorder
    • Bruxism
      • Istanbul, Turkey
        Marmara University School of Dentistry
      Sep 29, 2022

      Small Cell Lung Carcinoma Trial in Omaha (Durvalumab + Tremelimumab in combination with carboplatin and etoposide, Durvalumab in

      Terminated
      • Small Cell Lung Carcinoma
      • Durvalumab + Tremelimumab in combination with carboplatin and etoposide
      • Durvalumab in combination with carboplatin and etoposide
      • Omaha, Nebraska
        University of Nebraska Medical Center
      Feb 24, 2022

      Iron-deficiency Trial in Saskatoon (Low phytate pea powder, Regular pea powder, Placebo (maltodextrin))

      Completed
      • Iron-deficiency
      • Low phytate pea powder
      • +2 more
      • Saskatoon, Saskatchewan, Canada
        University of Saskatchewan
      Oct 11, 2022

      Mandibular Nerve Lateralization on Nutrition and Speech

      Not yet recruiting
      • Alveolar Bone Loss
      • Bone Deformity
        • Istanbul, Turkey
          Marmara University School of Dentistry
        Jan 10, 2023

        Lung Cancer Trial in Manchester (Once daily radiotherapy, Twice daily radiotherapy)

        Completed
        • Lung Cancer
        • Once daily radiotherapy
        • Twice daily radiotherapy
        • Manchester, United Kingdom
          The Christie NHS Foundation Trust
        Sep 5, 2022

        Critical Illness Trial in Bordeaux, Clermont-Ferrand, La Roche-sur-Yon (Androgel Topical Product, Placebo, Physical performance)

        Not yet recruiting
        • Critical Illness
        • Androgel Topical Product
        • +6 more
        • Bordeaux, France
        • +3 more
        Apr 21, 2023

        Effect of Oestrogen on Musculoskeletal Outcomes

        Recruiting
        • Contraception
        • +2 more
          • Camberley, Surrey, United Kingdom
            Army Health and Performance Laboratory
          Oct 18, 2022